Literature DB >> 35450194

Clinical characteristics and surgical treatment of idiopathic uveal effusion syndrome.

Zhi-Jun Shen1, Lin Shen1, Hong Wang1.   

Abstract

AIM: To investigate the clinical characteristics of idiopathic uveal effusion syndrome (IUES) and to identify effective surgical modalities for its treatment.
METHODS: This retrospective analysis included clinical data of 33 eyes from 26 patients with IUES at Beijing Tongren Hospital. Records of eye examinations, ocular ultrasound, ocular ultrasound biomicroscopy (UBM), and follow-up surgical treatment were reviewed and analyzed.
RESULTS: Of 26 patients, 17 (65.4%) were male and 9 (34.6%) were female. The average age of disease onset was 46.8y (range: 22-64y). Seven patients (26.9%) showed retinal detachment in both eyes at presentation. B-ultrasound showed the presence of retinal detachment in one eye or both eyes. All patients had binocular ciliary leakage and detachment. Eyes with retinal detachment underwent four-quadrantic partial-thickness sclerectomy and sclerostomy. Subretinal fluid resolution was achieved within 6mo. Recurrence was observed in three eyes and was resolved with re-operation.
CONCLUSION: Ophthalmic ultrasound and UBM, among others, can be helpful in the diagnosis of IUES. Sclerectomy and sclerostomy are surgical modalities that can successfully treat the disease. Some patients may experience recurrence after surgery; reoperation remains safe and effective for them. Long-term follow-up is essential in such settings. International Journal of Ophthalmology Press.

Entities:  

Keywords:  idiopathic uveal effusion syndrome; recurrence; retinal detachment; sclerectomy; sclerostomy

Year:  2022        PMID: 35450194      PMCID: PMC8995719          DOI: 10.18240/ijo.2022.04.13

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  22 in total

1.  Uveal effusion in Hunter's syndrome. Evidence that abnormal sclera is responsible for the uveal effusion syndrome.

Authors:  A K Vine
Journal:  Retina       Date:  1986 Winter-Spring       Impact factor: 4.256

2.  Scleritis With Uveal Effusion From Alirocumab.

Authors:  Mark P Breazzano; Royce W S Chen
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

3.  Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome).

Authors:  J D Gass; S Jallow
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

4.  Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology.

Authors:  M Uyama; K Takahashi; J Kozaki; N Tagami; Y Takada; H Ohkuma; H Matsunaga; T Kimoto; T Nishimura
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

Review 5.  Uveal effusion syndrome.

Authors:  Mohammed Elagouz; Dinu Stanescu-Segall; Timothy L Jackson
Journal:  Surv Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 6.048

6.  The uveal effusion syndrome and trans-scleral flow.

Authors:  J V Forrester; W R Lee; P R Kerr; H S Dua
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  The ultrastructural organization of proteoglycans and collagen in human and rabbit scleral matrix.

Authors:  R D Young
Journal:  J Cell Sci       Date:  1985-03       Impact factor: 5.285

Review 8.  Quadrantic vortex vein decompression with subretinal fluid drainage for manangement of Nanophthalmic choroidal effusions- a review of literature and case series.

Authors:  Anadi Khatri; Sweta Singh; Kriti Joshi; Muna Kharel
Journal:  BMC Ophthalmol       Date:  2019-10-24       Impact factor: 2.209

Review 9.  Uveal Effusion Syndrome as the Initial Manifestation of Primary Sjögren's Syndrome and Review of the Literature.

Authors:  Chunli Chen; Shuya Wang; Guanhong Zhang; Xiaorong Li
Journal:  Ocul Immunol Inflamm       Date:  2020-08-04       Impact factor: 3.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.